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Abstract 
Plasma membrane oxidoreductases have been described in all cells and use extracellular impermeant electron acceptors (DCIP, 
Ferricyanide) that are reduced by NADH. They appear to regulate the overall cell activity in response to oxidative stress from the cellular 
environment. An NADH-DCIP reductase has been described at the plasma membrane of NB41A3, a neuroblastoma cell line (Zurbriggen 
and Dreyer (1993) Biochim. Biophys. Acta 1183, 513-520) whose activation with extracellular impermeant substrates promotes cell 
growth. Elutriation was performed to separate cells and the various fractions were analysed for enzyme activity on intact cells combined 
with flow cytometry. These studies howed that the enzyme is mostly induced and activated uring the G1 and during the G2/M-phases. 
These observations were further corroborated with specific inhibitors of the cell cycle. A three-fold increase in enzyme activity was 
observed in the presence of c~-amanitin, a specific cell cycle inhibitor of the Gl-phase. Taxol, a specific inhibitor of the M-phase, also 
induces a significant increase in enzyme activity. FACS analysis of taxol-treated and a-amanitin-treated c lls corroborated these data. The 
cells have been synchronized and the enzyme activity was measured at different time intervals. An activity increase was observed after ca. 
2-3 h, that corresponds to a raise in the M-phase, according to FACS data. Furthermore, NTera-2 cells - a human neuroblastoma cell line 
that differentiates into fully mature neurones in the presence of retinoic acid - exhibit a 50% decrease in the enzyme activity during the 
G0-phase upon differentiation, compared to undifferentiated cells. Together the data presented in this paper show that this plasma 
membrane NADH-diaphorase affects cell growth and differentiation a d is strongly modulated at various phases of the cell cycle. 
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1. Introduction 
Plasma membrane redox enzymes have been demon- 
strated in all cell types but their real function is not yet 
established [1-3]. In response to hormones and other 
growth factors, they transfer electrons from reducing agents 
in the cytoplasm (e.g. NADH) to external impermeable 
oxidants such as ferricyanide or other externally generated 
substrates (e.g. ascorbate free radicals, thiols) as an elec- 
tron acceptor [4]. Plasma membranes contain b-cytochro- 
mes, flavin, iron, and quinones, therefore components for 
Abbreviations: DC1P, dichlorophenol-indophenol; DMEM, Dulbecco's 
modifified Eagle's medium. 
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electron transport are present but their participation, except 
for quinone, has not been demonstrated [2,4]. Several 
systems are identified in animal and plant plasma mem- 
branes and include: NADH-diaphorase [5] and NADH- 
oxidase (controlled by growth hormones), iron reductases, 
NADH-cytochrome b 5 reductase, NADH-Ferricyanide re- 
ductase [6,7], peroxidase, superoxide-generating NADPH 
oxidase, semi-dehydro-ascorbate reductase [8-11], xan- 
thine oxidase [12], thioredoxin reductase [13], or redox 
enzymes involved in the photo-reduction i some pho- 
totropic cells [14], etc. In a different way, phagocytes 
possess a superoxide-generating oxidase that is essential 
for the efficient killing of microorganisms [15] and is a 
special case of plasma membrane oxydoreductase. Re- 
duced pyridine nucleotides are substrates for the plasma 
membrane dehydrogenases and natural ferric chelates or 
ferric transferrin can act as electron acceptors. 
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Stimulation of electron transport with impermeable oxi- 
dants and hormones activates proton release from cells 
[ 16]. Inhibitors of electron transport, such as certain antitu- 
mor drugs, inhibit proton release. The high ratio of protons 
released to electrons transferred, the stimulation of proton 
release by sodium ions and the inhibition by amiloride 
together suggest that electron transport activates the 
Na+/H ÷ antiport [16]. The nature and components of the 
electron transport system and the mechanism by which 
proton release is activated are unknown. Cell proliferation 
and a more oxidising state (e.g. a higher NAD÷/NADH 
ratio) in the cytosol are associated in some mammalian cell 
types [17] and electron flow through the plasma membrane 
oxidoreductases also stimulates growth and cell prolifera- 
tion [l 8]. Several studies have described the effects of cell 
transformation o  plasma membrane oxidoreductases [19]. 
Transformation of 3T3 cells by SV40 virus changes the 
properties of a transplasma membrane lectron transport 
activity. Bombesin, a mitogenic neuropeptide that stimu- 
lates proliferation of Swiss 3T3 cells, also stimulates 
transplasma membrane reduction of diferric transferrin or 
ferricyanide [20]. From these and other studies a function 
of transplasma membrane oxidoreductases in cell growth, 
proliferation, transformation and differentiation is impli- 
cated [3-5,9,18,21]. In addition activation of transplasma 
membrane oxidoreductases is also related to exocytosis of 
clathrin-coated vesicles as well as to receptor-mediated 
and adsorptive ndocytosis [22]. 
In previous studies we have described a variety of 
isoforms of oxidoreductases in purified synaptic plasma 
membranes from rat or beef brain and their subunit compo- 
sition has been characterised [23-25]. The presence of a 
NADH-DCIP reductase in the plasma membrane of a 
neuroblastoma cell line, NB41A3, and its purification have 
also been reported [5]. In NB41A3 the enzyme accounts 
for over one third of total cellular diaphorase and strongly 
affects cell growth. Low substrate concentrations promote 
a 75% increase in cell growth [5]. 
In the present report he function of this enzyme during 
cell proliferation and differentiation has been investigated 
by means of activity measurements on intact cells and by 
flow cytometry at different stages of development. From 
these studies, it clearly appears that the enzyme is highly 
activated at specific stages during the cell cycle and turned 
off after differentiation. 
2.2. Growth of  neuroblastoma cells NB41A3 and NTera-2 
NB41A3 cells (from ATCC) were grown according to 
Agustini and Sato [26]. Confluent monolayer cultures were 
trypsinized in the presence of 0.25% trypsin and 0.1% 
EDTA and the cell suspension was pelleted at 500 X g for 
10 min. The pellet was washed with PBS, re-centrifuged 
and diluted in the same buffer to the appropriate final 
concentration. 
NTera-2 neuroblastoma cells (from ATCC) were han- 
dled under similar conditions. This cell line differentiates 
into neurones in the presence of 10 -5 M trans-retinoic 
acid. After incubation for 3-4 days in DMEM medium 
containing 10% FCS, cell differentiation is induced by 
incubation for 3 days in DMEM medium containing retinoic 
acid, followed by a medium change and a further incuba- 
tion in the same medium containing retinoic acid for 4 
more days. 
2.3. Membrane NADH-DCIP reductase activity measure- 
ments in cultured cells 
NADH-DCIP reductase activity was tested according to 
[27]. In all cases, activity measurements were performed in 
triplicates. Ca. 10 6 intact cells in 800 Ixl PBS buffer were 
incubated for 1 min before addition of 100 Ixl of 1.3 mM 
NADH, followed after 30 s by the addition of 100 ixl of 
0.44 mM DCIP. After incubation for 90 s at room tempera- 
ture the absorption change at 600 nm was measured over 2 
min. Where necessary, appropriate modifications were per- 
formed, as mentioned in the figures. 
2.4. Elutriation 
Elutriation was performed in a Beckmann JE-5.0 Elutri- 
ation system that has been cooled to 4°C and washed with 
cold PBS. At 2800 rpm the system was loaded with ca. 
108 cells at a flow rate of 10.5 ml/min. The elutriation 
started at a flow rate of 31 ml/min and was terminated at 
231 ml/min. 50 ml fractions were collected. The cells 
from each fractions were then centrifuged at 500 X g for 
10 min and resuspended in 2 ml PBS. 
2.5. FACS-analysis 
2. Mnterial  and methods 
2.1. Chemicals 
et-Amanitin, taxol, dimethyl-sulfoxide, Triton X-100 and 
NAD(H) were purchased from Fluka TM. DCIP, DT-di- 
aphorase (EC.1.8.1.4), and PMSF were from Sigma TM, 
growth media, DMEM, foetal calf serum, trypsin and PBS 
were from Seromed. 
l0  6 cells in 0.3 ml PBS (4°C) were mixed dropwise 
with 0.9 ml ice-cold ethanol. After incubation for 12 h at 
4°C, cells were washed twice in PBS and suspended in 0.9 
ml PBS. 0.1 ml propidium Iodide (50 mg/ml  in 0.38 mM 
Na-citrate buffer, pH 7.0) was added, followed by 10 Ixl 
RNase (DNase-free, 1 mg/ml)  and the suspension was 
incubated for 30 min at 37°C. Thereafter cells were kept in 
the dark until use. RNase (10 mg/ml  in 0.01 M Na-acetate, 
pH 5.2) had been freed of DNase by treatment for 15 min 
at 100°C and slow cooling up to RT, then neutralised with 
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addition of 0.1 vol 1 M Tris-HC1, pH 7.4 and kept at 
- 20°C. 
2.6. Cell synchronisation 
This was performed according to Minana et al. [28]. To 
synchronise at G 0, 4 × 105 cells/ml per well were seeded 
in 24-well plates and cultured in MEM without glutamine 
and containing 0.5% inactivated FCS. After 48 h of incu- 
bation in a moist 5% CO2/95% air incubator at 37°C, 
most of the cells were in the G o phase. The G o syn- 
chronous culture was obtained by transferring the resting 
cells into complete medium (MEM containing 10% FCS). 
To synchronise cells at the Gt /S  boundary, 1mM hydrox- 
yurea was added to the above culture 8 h after the medium 
exchange. After 14 h of incubation, the cells were washed 
and transferred to fresh complete medium. After different 
incubation times, (as indicated in the figures) cells were 
then trypsinized, washed trice with PBS and intact cells 
were then tested for DCIP-reductase activity. 
2.7. Other assays 
Protein concentrations were determined according to the 
micro-BCA method of Pierce TM or according to Bradford 
[29]. 
3.  Resu l ts  
NB41A3 cells are neuroblastoma cells that are easily 
cultivated and grown and display high amounts of plasma 
membrane NADH-DCIP reductase activity [5]. During our 
studies with NB41A3 cells, we observed that the enzyme 
activity fluctuates from probe to probe, depending upon 
the culture conditions. Enzymatic activity was lowest at 
confluent cell's concentration in culture dishes. On the 
basis of this observation we; investigated the fluctuation in 
activity during cell cycle. 
3.1. Elutriation and FACS-analysis 
At near confluency cells were separated by means of 
elutriation (Fig. 1). Intact cells from the first fractions to 
be elutriated isplayed highest plasma membrane NADH- 
DCIP reductase activity, about 0.2 mU/mg protein. This 
early peak corresponds to the lightest cells that mainly had 
undergone cell division. In the following elutriation frac- 
tions the NADH-DCIP reductase activity measured on 
intact cells was only ca. 0.03 mU/mg,  ca. 15% of the 
activity displayed in the initial peak On the other hand 
intact cells from the fractions elutriated last at flow rates 
from 130 to 250 ml/min, and corresponding to cells 
shortly before division, again displayed a very high activ- 
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Fig. 1. Elutriation of NB41A3. About 108 cells were submitted to 
elutriation (see Section 2). Intact NB41A3 ceils near confluency were 
applied in PBS at a flow rate of ca 10.5 ml/min and elutriation was 
initiated at an initial flow rate of ca. 30 ml/min. Each collected fraction 
(50 ml) was then centrifuged at 500× g for 10 min the pellet was 
resuspended in 2 ml PBS and the NADH-DC1P reductase activity was 
measured on intact cells together with protein determination, asdescribed 
in Section 2. Activity is expressed in p+mol DCIP reduced per min per mg 
of protein. Each measurement has been performed at least in triplicates. 
relationship between the plasma membrane NADH-DCIP 
reductase activity and cell division can be inferred. 
To further investigate this correlation cells were submit- 
ted to FACS analysis (Fig. 2). First a FACS analysis of the 
whole cell population before elutriation was undertaken as 
a control (Fig. 2A). These cells displayed a normal cell 
cycle pattern with cells mostly in the G1 phase, but also in 
the S phase and significantly in the G2/M phase. There- 
after various fractions from the elutriation experiments 
were also submitted to FACS analysis. Pooled fractions at 
31 to 42 ml/min of the elutriation experiment, correspond- 
ing to the initial peak of NADH-DCIP reductase activity, 
were analyzed, showing that cells are almost completely in 
I 
el 
. . . . . . . .  t~a,i ®,~ ' ' ; ' " '  ' 
PZ PI 
~d . . . . . . . .  l e~ 
P! PI 
Fig. 2. FACS analysis of NB41A3 cells after elutriation. Fractions after 
elutriation were pooled, prepared for FACS analysis and submitted to 
FACS analysis according to Section 2. (A) Control analysis of NB41A3 
cells before elutriation; (B) pooled fractions of intact NB41A3 cells 
elutriated at a flow rate of 31-42 ml/min; (C) pooled fractions of intact 
NB41A3 cells elutriated at a flow rate of 42-78 ml/min; (D) pooled 
fractions of intact NB41A3 cells elutriated at a flow rate of 78-231 
ml/min. PI = fluorescence intensity. 
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the Gl-phase (Fig. 2B) in strong contrast o the control. 
These cells display little S-phase and virtually no G2/M 
phase. On the other hand, cells from fractions at 42 to 78 
ml/min, i.e. fractions that displayed lowest plasma mem- 
brane NADH-DCIP reductase activity, are found mainly in 
the S-phase (Fig. 2C). Finally cells elutriated last (fractions 
at 78 to 231 ml/min), that displayed high plasma mem- 
brane NADH-DCIP reductase activity, were almost com- 
pletely found in the G2/M phase (Fig. 2D). 
3.2. Cell cycle inhibitors 
To further corroborate these data we investigated the 
effects of some cell cycle inhibitors on the plasma mem- 
brane NADH-DCIP reductase and on the cell cycle. The 
cell cycle has been blocked at various stages by means of 
specific inhibitors. Shortly before activity measurements, 
cells treated with the inhibitors were washed to remove the 
cell cycle inhibitor and to prevent unspecific interferences 
with the assay, e~-amanitin s a specific inhibitor of RNA 
polymerase II and therefore is a specific cell cycle blocker 
at the G1 phase [28]. In the presence of a-amanitin intact 
NB41A3 cells display a drastic increase in plasma mem- 
brane NADH-DCIP reductase activity (Fig. 3). The raise in 
activity is concentration dependent, with a 300% increase 
in enzyme activity being observed with 10 p~g/ml e~- 
amanitin. 
FACS analysis of cells treated with increasing concen- 
trations of o~-amanitin were performed (Fig. 4A-D). Un- 
treated control cells display a normal FACS pattern (Fig. 
4A) whereas e~-amanitin treated cells display a severe drop 
of both the S-phase and the G2/M-phase, concomitant 
with an increase of the Gl-phase (Fig. 4B-C). The effect 
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Fig. 3. Plasma membrane NADH-DCIP reductase activity of NB41A3 
cells treated with c~-amanitin. About 106 NB41A3 cells were grown for 
48 h in the presence of cx-amanitin at the indicated concentrations. Then 
the cells were trypsinized, collected, washed trice in PBS to remove 
a-amanitin and the NADH-DCIP reductase activity was measured on 
treated, intact NB41A3 cells. Activity is expressed in ixmol DC1P 
reduced/min per mg of protein. Each measurement has been performed 
at least in triplicates and the mean values with SD are presented. 
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Fig. 4. FACS analysis of ~x-amanitin-treated NB41A3. Cells were treated 
as described in Fig. 3. After 48 h in the presence of a-amanitin cells were 
collected, washed and submitted to FACS analysis as described in Section 
2. (A) untreated cells as a control; (B) cells treated with 2,5 ~g/ml  
cx-amanitin; (C) cells treated with 5 ~g/ml  a-amanitin; (D) cells treated 
with 10 Ixg/ml a-amanitin. PI = fluorescence intensity. 
tivity increase of the plasma membrane NADH-DCIP re- 
ductase. 
Another possible cell cycle blocker at the Gl-phase is 
DMSO. This reagent has been used as cell cycle blocking 
agent in various cells [30-33]. NB41A3 cells incubated in 
the presence of 1.5% DMSO for 96 h also displayed a 46% 
increase in plasma membrane NADH-DCIP reductase ac- 
tivity over controls, confirming the results obtained with 
a-amanitin. 
The cell cycle can also be specifically blocked in the M 
phase by means of taxol [32] which blocks the mitosis in 
the transition from the metaphase to the anaphase. In the 
presence of 10 nM taxol a 45% increase in plasma mem- 
brane NADH-DCIP reductase was found with intact 
U 






Fig. 5. Plasma membrane NADH-DC1P reductase activity of NB41A3 
cells treated with taxol. 106 ceils were grown for 48 h in the presence of 
taxol at the indicated concentrations. Then the cells were trypsinized, 
collected, wahsed trice in PBS to remove taxol and the NADH-DCIP 
reductase activity was measured on intact cells. Activity is expressed in
p~mol DCIP reduced/min per mg of protein. Measurements have been 
performed at least in triplicates. Mean values with SD are presented. 
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NB41A3 cells (Fig. 5). The activity increase is concentra- 
tion-dependent up to ca. 10 nM taxol. At higher taxol 
concentration a  activity increase is observed over controls 
also, but of smaller intensity, probably due to the toxic 
effects of taxol (data not shown). FACS analysis of taxol 
treated cells (between 1 and 10 nM taxol) were then 
undertaken (Fig. 6). Compared to untreated cells (Fig. 6A) 
that display a normal FACS profile, taxol-treated cells 
clearly show a blockage in the G2/M phase in a concen- 
tration dependent manner (Fig. 6B-D). This indicates that 
blocking the cells at the G2/M phase induces an increase 
in the plasma membrane NADH-DCIP reductase activity. 
3.3. Cell synchronisation 
Cultured cells normally consist of a mixture of various 
cell populations at various stages in the cell cycle. To get a 
homogenous population, NB41A3 cells were synchronised 
in the G1/S  phase, as described under Section 2. There- 
after the enzyme activity has been measured on intact cells 
at various times (Fig. 7) and FACS analysis has been 
performed (Fig. 8). After synchronization a first raise in 
the plasma membrane NADH-DCIP reductase activity was 
observed ca. 2 h after the G1/S  transition, followed by a 
second smaller peak after ca. 5.5 h. In the first activity 
peak the specific activity almost doubled over controls, 
whereas during the second peak the increase in activity 
was about 25% over resting cells. Immediately after syn- 
chronization cells were mainly in the G 1 phase as expected 
(Fig. 8A). After ca. 2 h a raise in the G2/M-phase was 
observed (Fig. 8B) that correlates with the raise in 
NADH-DCIP reductase activity from the first peak (Fig. 
7). The G2/M-phase then declines (Fig. 8C) in correlation 
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Fig. 6. FACS analysis of taxol-treated NB41A3. Cells were treated as 
described inFig. 3. After a 48-h incubation i  the presence oftaxol, cells 
were trypsinized, collected and submitted to FACS analysis as described 
in Section 2. (A) control, untreated cells; (B) cells treated with 1 nM 
taxol; (C) cells treated with 5 nM taxol; (D) cells treated with 10 nM 
taxol. PI = fluorescence intensity. 
0.0  
0 .4  
O2 
0.1 .  
0 .0  * i i i i i i i 
0 1 2 3 4 S 6 7 8 
free a lb r  syaehremlmdlel .m GtlS (11) 
Fig. 7. Plasma Membrane NADH-DCIP reductase activity of NB41A3 
cells after synchronisation. NB41A3 cells were synchronised as described 
in Section 2by growing with 0.5% FBS in MEM without glutamine for 
48 h, followed by medium change for 8 h and by treatment with 1 mM 
hydroxyurea for 14 h. After synchronisation, cellaliquots were collected 
at various times as indicated and the NADH-DCIP activity was measured. 
Activity is expressed in ~mol DCIP reduced/rain per mg of protein. 
Each measurement hasbeen performed atleast in triplicates and the mean 
values with SD are presented. 
with the drop in enzyme activity. About 4 hours after 
G1/S  transition, i.e. when the NADH-DCIP reductase 
activity is minimal (Fig. 7), an increase in the S-phase is 
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Fig. 8. FACS analysis of NB41A3 cells after synchronisation, NB41A3 
Cells were synchronized as in Fig. 7. At various times, as indicated, the 
cells were removed from the medium, trypsinized, washed and submitted 
to FACS analysis. (A) FACS analysis mmediately after synchronization 
(t = 0 rain) (B) FACS analysis of NB41A3 cells 2 h after synchronization 
(C) FACS analysis of NB41A3 cells 2.75 h after synchronization (D) 
FACS analysis of NB41A3 cells 4.25 h after synchronization (E) FACS 
analysis of NB41 A3 cells 5.25 h after synchronization (F) FACS analysis 
of NB41A3 cells 6.25 h after synchronization. 
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Table 1 
NADH-DCIP reductase activity in differentiated and undifferentiated 
NTera-2 cells 




NTera-2 cells were grown in DMEM in the presence of 10% FCS with or 
without 10 -5 M retinoic acid for 3 days. After a medium change and a 
further sub-cultivation for 4 days in the same medium cells were 
trypsinized, washed thrice with PBS and assayed for plasma membrane 
NADH-DC1P reductase activity. Control, undifferentiated cells were 
grown under the same conditions without retinoic acid. Activity measure- 
ments were performed in triplicates 
clearly observed by means of FACS analysis (Fig. 8D). 
The raise in the S-phase then progressively decreases as 
the cell cycle undergoes completion (Fig. 8E and F). 
3.4. Differentiation of NTera-2 cells 
According to the above observations a change in the 
plasma membrane NADH-DCIP reductase correlates with 
specific cell cycle phases. Therefore it is expected that 
during differentiation, i.e. when cells are in the G1 and 
M-phases, a strong increase in activity should be observed 
over differentiated cells, where cells are mostly in the 
G0-phase. To check this hypothesis we have used NTera-2 
cells, a human neuroblastoma cell line that can be differen- 
tiated in the presence of 10 IxM retinoic acid [34]. Undif- 
ferentiated cells display a basal activity for the plasma 
membrane NADH-DCIP reductase of ca. 4-5 mU/mg 
protein (Table 1). However when the cells are exposed to 
low amounts of retinoic acid for several days an increase 
in enzyme activity is observed that correlates well with the 
observed cell differentiation. After 7 days of exposure to 
10 ixM retinoic acid the enzyme activity has increased 
more than 2-fold over the controls, as shown in Table 1. 
These observations corroborate the other data and further 
establishes a good correlation between enzyme activation 
and cell differentiation. 
It should also be noted that under normal cell culture 
conditions a significant amount (15-20%) of NB41A3 
cells undergo spontaneous differentiation i to morphologi- 
cally mature neurons, even in the absence of growth 
factors or retinoic acid in the medium. This explains in 
part why FACS analysis usually displays significant 
amounts of cells at the G0-phase, in the various conditions 
described above. 
4. Discussion 
The NADH-DCIP reductase that we have characterized 
in this and in a previous paper [5] is apparently very much 
related to the plasma membrane oxidoreductase d scribed 
in astrocytes by Mersel et al. [35,36] and Malviya et al. 
[37] and may also be similar to the NADH-ferricyanide 
reductase described by Cherry [6] or by Grebing [7]. A 
similar enzyme activity has been isolated from erythrocyte 
by Wang et Alaupovic [36]. In earlier studies [5]. we have 
shown that extracellular, impermeant electron acceptors 
stimulate growth of NB41A2 neuroblastoma cells, with 
ferricyanide or DCIP stimulating rowth by 75% at micro- 
molar concentrations The data presented here further char- 
acterize this enzyme and give evidence for that phe- 
nomenon. Elutriation studies show that the plasma mem- 
brane NADH-DCIP reductase is mostly induced and acti- 
vated during the GI and during the G2/M-phases. A 
300% increase in activity is observed in the presence of 
a-amanitin and a 50% increase with taxol, specific cell 
cycle inhibitors of the G1 and M phases respectively. 
These data could be corroborated by FACS analysis. Fur- 
thermore NTera-2 cells, a human neuroblastoma cell line 
that differentiates into fully mature neurones in the pres- 
ence of retinoic acid, exhibit a 50% decrease in plasma 
membrane NADH-DCIP reductase activity during the G0- 
phase upon differentiation, compared to undifferentiated 
cells. These data together show that the enzyme activity 
varies at various stages of the cell cycle and affects cell 
growth and differentiation. 
These studies are in agreement with observations made 
on melanoma cells, HeLa cells, Ehrlich Ascites or on other 
studies [38-47]. Growth factors rapidly modulate the elec- 
tron flow across the plasma membrane of living cells. A 
cyanide-insensitive NADH oxidase purified from rat liver 
plasma membranes i stimulated by growth factors and 
inhibited by agents that inhibit growth or induce differenti- 
ation (retinoic acid, calcitriol and the monosialo-ganglio- 
side GM 3) [41]. The enzyme is not affected by common 
inhibitors of microsomal or mitochondrial oxidoreductases. 
The stimulation by growth factors is decreased or absent 
with hepatoma plasma membranes [42,43]. Growth factors, 
EGF and transferrin also stimulate the reduction of exter- 
nal ascorbate free radical, a substrate of transplasma mem- 
brane oxidoreductase. By contrast wheat germ agglutinin 
inhibits this reduction, demonstrating, under physiological 
conditions, the operation of a growth factor- and lectin-re- 
sponsive lectron transport system at the cell surface in a 
cultured human cell line [47]. Ferric-lactoferrin, another 
growth stimulant in isolated rat liver plasma membranes, 
stimulates both the reduction of external ferric iron by 
cells and NADH oxidase activity or the amiloride-sensitive 
proton release from K562 cells [48]. In addition antitu- 
moral agents, such as adfiamycin, cis-dichlorodiamine- 
Pt(II), actinomycin D and bleomycin also inhibit both 
transplasma membrane oxidoreductases and cell growth 
[49-51]. Conjugates of adriamycin cross-linked to transfer- 
fin inhibit proliferation of K562 cells as well as oxido- 
reductase activity in the plasma membrane at concentra- 
tions ten times lower than concentrations of free adri- 
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amycin [44]. They are cytotoxic to human promyelocytic 
(HL-60) and erythroleukemic (K562) cells, growth inhibi- 
tion being higher for conjugates than for free adriamycin 
[45]. Pt(II) complexes are antitumoral in their cis but not 
trans form (although both forms bind DNA with similar 
binding affinities) and 10 --7 M cis-Pt(II) completely in- 
hibits transplasma membrane oxidoreductases and growth 
within 3 min, whereas the trans-Pt(II) complex is inactive 
[50]. Retinoic acid and calcitriol also are inhibitors of both 
growth and transplasma membrane NADH oxidase in nor- 
mal and immortalised cells [44]. In normal HKc the plasma 
membrane NADH oxidase is stimulated by EGF whereas 
that of transformed cells, HKc/HPV16, is not. In all cases 
the enzyme is inhibited by calcitriol (lct-l,25-dihydroxy 
vitamin D-3) and retinoic acid [46]. Another clear indica- 
tion of the role of transplasma membrane oxidoreductases 
in the control of growth and proliferation comes from their 
effects on oncogene activation. The Ha-ras oncoprotein 
increases the activity of the transplasma membrane lec- 
tron transport system, since both externally added cy- 
tochrome c and ferricyanide are reduced at a faster rate 
when cells are expressing the Ha-ras oncogene [42]. Ha-ras 
transformed cells also extrude protons faster than their 
normal counterparts in response to stimulation by external 
oxidants, suggesting that transformation events, initiated 
by the expression of the Ha-ras oncoprotein p21, would 
control the transplasma membrane lectron transport sys- 
tem [42]. 
On the other hand, extracellular ferricyanide reduction 
is also inhibited by amiloride, a specific Na+/H+-antiport 
inhibitor [52,53]. This and other evidences that the plasma 
membrane oxidoreductases l ad to activation of Na+/H + 
exchange provide an alternative xplanation for their pro- 
liferative ffect. It has been suggested that the transplasma 
membrane NADH oxidoreductase could modulate the 
intracellular pH, by affecting the antiport leading to cell 
proliferation via a pathway probably involving MAP- 
kinase. Gaillard [54] have shown in PC12 cells that exter- 
nal ferricyanide induces a persistent intracellular acidifica- 
tion of ca. 0.25 pH-units, whereas no intracellular drop is 
observed after stimulation and proliferation by growth 
factors in the absence of an external electron acceptor. 
From these and our works, a function of plasma mem- 
brane NADH-oxidoreductases in cell differentiation is well 
established. Our report clarifies further that the enzyme is 
turned on at specific stages of the cell cycle. The molecu- 
lar mechanisms by which this regulation occurs, the trans- 
duction pathways and the implicataion of these effects on 
cellular fonctions remains to be further investigated. 
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